CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 9,239	$ 3,980
Short-term investments	0	5,000
Accounts receivable, net of allowance of $85 and $69 at March 31, 2024 and December 31, 2023, respectively	2,744	4,703
Other current assets	654	692
Total current assets	12,637	14,375
PROPERTY AND EQUIPMENT, NET	628	666
GOODWILL	8,102	8,102
INTANGIBLE ASSETS, NET	1,157	575
OTHER ASSETS	91	90
Total assets	22,615	23,808
CURRENT LIABILITIES:
Accounts payable	1,121	884
Accrued expenses	2,657	3,245
Equity awards liability	0	4
Liability for shares withheld	190	190
Deferred revenue	1,469	2,209
Total current liabilities	5,437	6,532
Total liabilities	5,437	6,532
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock - $0.01 par value; 30,000 shares authorized; Series A convertible preferred stock, zero shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	0	0
Common stock - $0.001 par value; 40,000,000 shares authorized; 19,404,561 and 19,354,335 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	19	19
Additional paid-in capital	151,166	150,822
Accumulated deficit	(134,007)	(133,565)
Total stockholders’ equity	17,178	17,276
Total liabilities and stockholders’ equity	$ 22,615	$ 23,808